Top-News
Biotechnologie USA

vTv Therapeutics A News

Aktie
WKN:  A3EWXG ISIN:  US9183852048 US-Symbol:  VTVT
22,91 $
+0,00 $
0,00%
26.03.24 17:35:23
Handeln Depot/Watchlist
Aktienanzahl *
1,67 Mio.
Marktkapitalisierung *
42,73 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 21.11.2023

vTv Therapeutics A News

19.03.24 - PR Newswire
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT PR Newswire
22.02.24 - PR Newswire
CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE
CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE PR Newswire
27.09.23 - PR Newswire
CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19
CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-​BLIND, PLACEBO-​CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL ...
26.09.23 - PR Newswire
Cantex and Allegheny Health Network Announce Initiation of a Phase 1/2 Study of Azeliragon in Patients Refractory to First-Line Treatment of Metastatic Pancreatic Cancer
Cantex and Allegheny Health Network Announce Initiation of a Phase 1/2 Study of Azeliragon in Patients Refractory to First-​Line Treatment of Metastatic Pancreatic Cancer PR Newswire
18.09.23 - PR Newswire
CANTEX PHARMACEUTICALS AND LENOX HILL HOSPITAL ANNOUNCE INITIATION OF A PHASE 2 STUDY OF RAGE INHIBITOR AZELIRAGON AS A FRONT-LINE TREATMENT FOR UNMETHYLATED GLIOBLASTOMA
CANTEX PHARMACEUTICALS AND LENOX HILL HOSPITAL ANNOUNCE INITIATION OF A PHASE 2 STUDY OF RAGE INHIBITOR AZELIRAGON AS A FRONT-​LINE TREATMENT ...
10.08.23 - PR Newswire
Cantex Pharmaceuticals Announces Article Published in npj Breast Cancer Highlighting Potential Role of RAGE Inhibition to Prevent Metastasis in Triple-Negative Breast Cancer
Cantex Pharmaceuticals Announces Article Published in npj Breast Cancer Highlighting Potential Role of RAGE Inhibition to Prevent Metastasis in Triple-​Negative Breast Cancer PR ...
15.06.23 - PR Newswire
CANTEX PHARMACEUTICALS TO PRESENT AT THE MEDINVEST ONCOLOGY INVESTOR CONFERENCE IN BOSTON
CANTEX PHARMACEUTICALS TO PRESENT AT THE MEDINVEST ONCOLOGY INVESTOR CONFERENCE IN BOSTON PR Newswire
20.04.23 - PR Newswire
Cantex and Michigan Medicine Announce Initiation of a Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Clinical Study to Determine the Safety and Efficacy of Azeliragon in the Treatment of Patients Hospitalized for COVID-19
Cantex and Michigan Medicine Announce Initiation of a Randomized, Double-​Blind, Placebo-​Controlled Phase 2/3 Clinical Study to Determine the Safety and Efficacy of Azeliragon in ...
06.03.23 - PR Newswire
Cantex and Miami Cancer Institute Announce FDA Clearance for a Clinical Trial Investigating Azeliragon Combined with Stereotactic Radiosurgery for the Treatment of Brain Metastases
Cantex and Miami Cancer Institute Announce FDA Clearance for a Clinical Trial Investigating Azeliragon Combined with Stereotactic Radiosurgery for the Treatment of Brain ...
27.02.23 - PR Newswire
Cantex Receives FDA "Study May Proceed" Letter for Phase 2 Clinical Trial of Azeliragon for the Treatment of Unmethylated Glioblastoma
Cantex Receives FDA "Study May Proceed" Letter for Phase 2 Clinical Trial of Azeliragon for the Treatment of Unmethylated Glioblastoma PR Newswire
09.01.23 - PR Newswire
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF GLIOBLASTOMA
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF GLIOBLASTOMA PR Newswire
25.07.22 - PR Newswire
Thinking about buying stock in Aethlon Medical, Tonix Pharmaceuticals, REE Automotive, Kaival Brands, or vTv Therapeutics?
Thinking about buying stock in Aethlon Medical, Tonix Pharmaceuticals, REE Automotive, Kaival Brands, or vTv Therapeutics? PR Newswire
01.06.22 - PR Newswire
Thinking about buying stock in Tonix Pharmaceuticals, View, vTv Therapeutics, TherapeuticsMD, or Cassava Sciences?
Thinking about buying stock in Tonix Pharmaceuticals, View, vTv Therapeutics, TherapeuticsMD, or Cassava Sciences? PR Newswire
29.03.22 - PR Newswire
vTv Therapeutics Announces 2021 fourth Quarter and Full Year Financial Results and Provides Corporate Update
vTv Therapeutics Announces 2021 fourth Quarter and Full Year Financial Results and Provides Corporate Update PR Newswire
03.03.22 - PR Newswire
vTv Therapeutics Announces CEO Transition
vTv Therapeutics Announces CEO Transition PR Newswire
20.10.21 - PR Newswire
vTv Therapeutics Announces Deepa Prasad as New President and CEO
vTv Therapeutics Announces Deepa Prasad as New President and CEO PR Newswire
27.09.21 - PR Newswire
Thinking about buying stock in Camber Energy, Rewalk Robotics, vTv Therapeutics, Quantumscape, or Northern Dynasty Minerals?
Thinking about buying stock in Camber Energy, Rewalk Robotics, vTv Therapeutics, Quantumscape, or Northern Dynasty Minerals? PR Newswire
24.09.21 - PR Newswire
Thinking about buying stock in Capricor Therapeutics, vTv Therapeutics, Li-Cycle Holdings, Predictive Oncology, or Rewalk Robotics?
Thinking about buying stock in Capricor Therapeutics, vTv Therapeutics, Li-Cycle Holdings, Predictive Oncology, or Rewalk Robotics? PR Newswire
22.06.21 - PR Newswire
Thinking about buying stock in vTv Therapeutics, Score Media and Gaming, Bio-Path Holdings, Anavex Life Sciences, or Atossa Therapeutics?
Thinking about buying stock in vTv Therapeutics, Score Media and Gaming, Bio-Path Holdings, Anavex Life Sciences, or Atossa Therapeutics? PR Newswire
20.04.21 - PR Newswire
Thinking about buying stock in Microvision, Lineage Cell Therapeutics, vTv Therapeutics, electroCore, or Arcadia Biosciences?
Thinking about buying stock in Microvision, Lineage Cell Therapeutics, vTv Therapeutics, electroCore, or Arcadia Biosciences? PR Newswire

Newssuche

Videos

newspaper
03.05.24 -13,45%
Technical Trading: Gold freitags Long
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »